M. Howard Morse, partner in the firm's Antitrust and Trade Regulation Practice, is a speaker at the American Conference Institute conference Maximizing Pharmaceutical Patents Life Cycles held in New York City on October 23-24, 2006.  Mr. Morse will discuss "Settlements Between Brand Name and Generic Pharmaceutical Companies and the Antitrust Implications of those Settlements."